Skip to content
ISRG·Nasdaq·US

Intuitive Surgical

Intuitive Surgical designs, manufactures, and sells robotic-assisted surgical systems (the da Vinci surgical systems) and the Ion endoluminal system, along with related instruments, accessories, learning, and support services, to hospitals and healthcare facilities. It sells its products and services through direct sales organizations and distributors in the U.S. and internationally, including via a joint venture with Fosun Pharma in China.

Source: SEC 10-K Feb 3, 2026

Recent Activity

Updated Oct 24, 2026
–Intuitive Surgical tightened its 2026 forecast for growth in da Vinci robotic surgery procedures, indicating slower growth than previously projected.

Past updates are part of the Pro plan.

Thematic Position

ISRG

Relationship Groups

Suppliers1
Partners1
Competitors3

Relationship details are part of the Pro plan.

Ended Relationships

1 ended relationship · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

tarifftrade measure
US baseline and reciprocal tariff framework raises import costs on components
SEC 10-KFeb 3, 2026

The full regulatory passage is part of the Pro plan.

24 more · Regulatory and geopolitical insights are part of the Pro plan.